<DOC>
	<DOCNO>NCT01052688</DOCNO>
	<brief_summary>To collect sample purpose develop optimize vitro noninvasive prenatal diagnostic ( NIPD ) test . The NIPD test employ circulate cell free ( ccff ) DNA extract whole blood sample collect woman pregnant fetus previously determine chromosomal abnormality . The NIPD result compare standard test result obtain test method karyotype , FISH , QF-PCR , and/or commercially available NIPD test .</brief_summary>
	<brief_title>Noninvasive Screening Affected Pregnancies : Assay Development &amp; Optimization Affected Pregnancies</brief_title>
	<detailed_description />
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>Subject female Subject 18 year old Subject less 8 36 week gestation Subject provide sign date informed consent Subject agree provide one 3050mL blood sample ( ) accordance protocol Subject current pregnancy fetus know chromosomal aneuploidy ( e.g . T13 , T18 , T21 ) Nonsingleton pregnancy one fetus know chromosomal aneuploidy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Down syndrome , aneuploidy , amniocentesis , chorionic villus sampling , Trisomy</keyword>
</DOC>